Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanoma.
Kaye SB, Wanders J, Clavel M, Verweij J, Piccart MJ, Smyth JF, Ten Bokkel Huinink WW, Wagener DJ, Judson IR, Cavalli F.
Kaye SB, et al.
Ann Oncol. 1992 May;3(5):406-8. doi: 10.1093/oxfordjournals.annonc.a058220.
Ann Oncol. 1992.
PMID: 1616895
Free article.
Clinical Trial.
A total of 91 eligible patients with metastatic cancer have been treated in a series of phase II trials of the novel pentacyclic pyrroloquinone, fosquidone. Tumour types were breast (24), ovary (25), head and neck (21) and melanoma (21). ...A total of 12 patients demonstra …
A total of 91 eligible patients with metastatic cancer have been treated in a series of phase II trials of the novel pentacyclic pyrroloquin …